I think i will hve to disagree with you on company's finances
ISCO just raised almost 16 millions $ with very minimal dilution
read :
<< in July we raised approximately $3 million, most of which came from a group of new investors new to ISCO. The capital will be used to fund our R&D programs, primarily our Parkinson's disease program where we intend to start a clinical trial in 2014. >>
and also :
<< As part of the offering, we also issued B Warrants which expired in October of this year, and we now have, through the execution of these B Warrants, raised a total of about $5.45 million from this transaction which along with our continued ability to manage our burn rate successfully downwards, now funds the Company well into 2014. >>
so , 5.45 mill. cash will get them well into 2014 and on top of that they just secured 10.25 millions $ from Lincoln Park Capital Fund, LLC December , 11
this 10.25 millions $ are without warrants and convertibles so very minimal dilution
read :
<< The Company controls the timing and amount of any future investment and LPC is obligated to make such purchases. There are no upper limits to the price LPC may pay to purchase ISCO common stock .. >>
and also :
<< LPC has agreed not to cause or engage in any manner whatsoever, any direct or indirect short selling or hedging of the Company's shares of common stock. >>
so basically they have around 16 millions $ cash available and if 5.45 mill. $ that they raised in July will get them well into 2014 now with almost 16 millions (5.45 + 10.25) should see them through 2015 and hopefully see them through trials
lets look at the revenues
from cc :
<< Sales for the three months ended September 30, 2013 were $1.7 million, up 41% from $1.2 million in the third quarter of 2012. Sales for our Lifeline Cell Technology subsidiary or LCT were $860,000, up 30% year-over-year, while Lifeline Skin Care or LSC revenues were $810,000, up 54% over the corresponding period in 2012. >>
and lets look at the revenues q by q in 2013 :
December ,31,2012 = 1 247 000 ( gross profit 315 K )
March , 31 , 2013 = 1 285 000 ( gross profit 951 K ))
June , 30 , 2013 = 1 457 000 ( gross profit 1,13 mill.)
September ,30 , 2013 = 1 670 000 ( gross profit 1,223 mill.)
as we can see sales have been inceasing for 4 quarter or more already and gross profit increasing along with it , so i dont know where did you get that we got 1 quarter of sales growth and need 2 more
It just a matter of time before ISCO explodes up and I think with next q numbers and IND filling we'll be looking at ISCO at way higher levels that it is now
just try to compare ISCO to the likes in the filed (actc,gern,stem,btx, etc...)that are valued 10-20 times more when ISCO in my opinion is way better fundamentally at the moment than them
on top officers are loaded with shares at .15 and .20
all in due time
in my honest opinion
gl
modrica
News 
Market Data 
Discover 
